Association of Plasma Lipids with White Matter Hyperintensities in Patients with Acute Ischemic Stroke

References

• Cannistraro RJ, Badi M, Eidelman BH, et al. CNS small vessel disease: a clinical review. Neurology. 2019;92:1146–1156. doi:10.1212/WNL.0000000000007654
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822–838. doi:10.1016/S1474-4422(13)70124-8
   PubMed Web of Science ®Google Scholar
• Sargurupremraj M, Suzuki H, Jian X, et al. Cerebral small vessel disease genomics and its implications across the lifespan. Nat Commun. 2020;11:6285. doi:10.1038/s41467-020-19111-2
   PubMed Web of Science ®Google Scholar
• Clancy U, Gilmartin D, Jochems ACC, et al. Neuropsychiatric symptoms associated with cerebral small vessel disease: a systematic review and meta-analysis. Lancet Psychiatry. 2021;8:225–236. doi:10.1016/S2215-0366(20)30431-4
   PubMed Web of Science ®Google Scholar
• Hu HY, Ou YN, Shen XN, et al. White matter hyperintensities and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 36 prospective studies. Neurosci Biobehav Rev. 2021;120:16–27.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang GY, Zhang ZE, He AQ, Gan J, Liu Z. White matter hyperintensities: a marker for apathy in Parkinson’s disease without dementia? Ann Clin Transl Neurol. 2020;7(9):1692–1701. doi:10.1002/acn3.51159
   PubMed Web of Science ®Google Scholar
• de Kort FAS, Coenen M, Weaver NA, et al. White matter hyperintensity volume and poststroke cognition: an individual patient data pooled analysis of 9 ischemic stroke cohort studies. Stroke. 2023. doi:10.1161/STROKEAHA.123.044297
   Web of Science ®Google Scholar
• Kopin L, Lowenstein C. Dyslipidemia. Ann Intern Med. 2017;167:Itc81–Itc96. doi:10.7326/AITC201712050
   PubMed Web of Science ®Google Scholar
• Ke D, Zhou F, Liang H, et al. Hypertriglyceridemia is associated with reduced leukoaraiosis severity in patients with a small vessel stroke. Behav Neurol. 2018;2018:1361780. doi:10.1155/2018/1361780
   PubMed Web of Science ®Google Scholar
• Schilling S, Tzourio C, Dufouil C, et al. Plasma lipids and cerebral small vessel disease. Neurology. 2014;83:1844–1852. doi:10.1212/WNL.0000000000000980
   PubMed Web of Science ®Google Scholar
• Georgakis MK, Malik R, Anderson CD, et al. Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol. Brain. 2020;143:597–610. doi:10.1093/brain/awz413
   PubMed Web of Science ®Google Scholar
• GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795–820. doi:10.1016/S1474-4422(21)00252-0
   PubMed Web of Science ®Google Scholar
• Tu WJ, Wang LD. China stroke surveillance report 2021. Mil Med Res. 2023;10(1):33. doi:10.1186/s40779-023-00463-x
   PubMed Web of Science ®Google Scholar
• Tu WJ, Zhao Z, Yin P, et al. Estimated burden of stroke in China in 2020. JAMA Netw Open. 2023;6(3):e231455. doi:10.1001/jamanetworkopen.2023.1455
   PubMed Web of Science ®Google Scholar
• Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683–1689. doi:10.1212/WNL.43.9.1683
   PubMed Web of Science ®Google Scholar
• de Leeuw FA, Karamujić-čomić H, Tijms BM, et al. Circulating metabolites are associated with brain atrophy and white matter hyperintensities. Alzheimers Dement. 2021;17:205–214. doi:10.1002/alz.12180
   PubMed Web of Science ®Google Scholar
• Martínez-González J, Escudero I, Badimon L. Simvastatin potenciates PGI(2) release induced by HDL in human VSMC: effect on Cox-2 up-regulation and MAPK signalling pathways activated by HDL. Atherosclerosis. 2004;174:305–313. doi:10.1016/j.atherosclerosis.2004.01.037
   PubMed Web of Science ®Google Scholar
• Keul P, Polzin A, Kaiser K, et al. Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy. FASEB J. 2019;33:1482–1495. doi:10.1096/fj.201801245R
   PubMed Web of Science ®Google Scholar
• Tran-Dinh A, Levoye A, Couret D, et al. High-density lipoprotein therapy in stroke: evaluation of endothelial SR-BI-dependent neuroprotective effects. Int J Mol Sci. 2020;22(1):106. doi:10.3390/ijms22010106
   PubMed Web of Science ®Google Scholar
• Park K, Yasuda N, Toyonaga S, et al. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology. 2007;69:974–978. doi:10.1212/01.wnl.0000266562.54684.bf
   PubMed Web of Science ®Google Scholar
• Schmitt S, Castelvetri LC, Simons M. Metabolism and functions of lipids in myelin. Biochim Biophys Acta. 2015;1851:999–1005. doi:10.1016/j.bbalip.2014.12.016
   PubMed Web of Science ®Google Scholar
• Atwood LD, Wolf PA, Heard-Costa NL, et al. Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke. 2004;35:1609–1613. doi:10.1161/01.STR.0000129643.77045.10
   PubMed Web of Science ®Google Scholar
• Chung C-P, Chou K-H, Peng L-N, et al. Associations between low circulatory low-density lipoprotein cholesterol level and brain health in non-stroke non-demented subjects. Neuroimage. 2018;181:627–634. doi:10.1016/j.neuroimage.2018.07.049
   PubMed Web of Science ®Google Scholar
• Duan D, Shen L, Cui C, et al. Association between low-density lipoprotein cholesterol and occipital periventricular hyperintensities in a group of Chinese patients: an observational study. Lipids Health Dis. 2017;16:48. doi:10.1186/s12944-017-0436-3
   PubMed Web of Science ®Google Scholar
• Smit RA, Trompet S, Sabayan B, et al. Higher visit-to-visit low-density lipoprotein cholesterol variability is associated with lower cognitive performance, lower cerebral blood flow, and greater white matter hyperintensity load in older subjects. Circulation. 2016;134:212–221. doi:10.1161/CIRCULATIONAHA.115.020627
   PubMed Web of Science ®Google Scholar
• Gouw AA, van der Flier WM, Fazekas F, et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke. 2008;39:1414–1420. doi:10.1161/STROKEAHA.107.498535
   PubMed Web of Science ®Google Scholar
• Jimenez-Conde J, Biffi A, Rahman R, et al. Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke. Stroke. 2010;41:437–442. doi:10.1161/STROKEAHA.109.563502
   PubMed Web of Science ®Google Scholar
• Stefaniak JD, Parkes LM, Parry-Jones AR, et al. Enzyme replacement therapy and white matter hyperintensity progression in Fabry disease. Neurology. 2018;91:e1413–e1422. doi:10.1212/WNL.0000000000006316
   PubMed Web of Science ®Google Scholar
• Vogt NM, Hunt JFV, Ma Y, et al. Effects of simvastatin on white matter integrity in healthy middle-aged adults. Ann Clin Transl Neurol. 2021;8:1656–1667. doi:10.1002/acn3.51421
   PubMed Web of Science ®Google Scholar
• Li W, Liu M, Wu B, Liu H, Wang LC, Tan S. Serum lipid levels and 3-month prognosis in Chinese patients with acute stroke. Adv Ther. 2008;25(4):329–341. doi:10.1007/s12325-008-0045-7
   PubMed Web of Science ®Google Scholar
• Pikija S, Sztriha LK, Killer-Oberpfalzer M, et al. Contribution of serum lipid profiles to outcome after endovascular thrombectomy for anterior circulation ischemic stroke. Mol Neurobiol. 2019;56(6):4582–4588. doi:10.1007/s12035-018-1391-3
   PubMed Web of Science ®Google Scholar
• Cheng Z, Zhang W, Zhan Z, Xia L, Han Z. Cerebral small vessel disease and prognosis in intracerebral haemorrhage: a systematic review and meta-analysis of cohort studies. Eur J Neurol. 2022;29(8):2511–2525. doi:10.1111/ene.15363
   PubMed Web of Science ®Google Scholar
• Griessenauer CJ, McPherson D, Berger A, et al. Effects of white matter hyperintensities on 90-day functional outcome after large vessel and non-large vessel stroke. Cerebrovasc Dis. 2020;49(4):419–426.
   PubMed Web of Science ®Google Scholar